BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pondé RAA. The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited. Arch Virol 2017;162:3587-602. [PMID: 28884240 DOI: 10.1007/s00705-017-3538-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Peliganga LB, Horta MAP, Lewis-ximenez LL. Enduring Challenges despite Progress in Preventing Mother-to-Child Transmission of Hepatitis B Virus in Angola. Pathogens 2022;11:225. [DOI: 10.3390/pathogens11020225] [Reference Citation Analysis]
2 Jiang B, Su R, Ren D, Zheng X, Cao Y, Mi Y, Wang F, Ma P. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients. Virus Res 2020;290:198117. [PMID: 32800804 DOI: 10.1016/j.virusres.2020.198117] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Setyowati D, Mubawadi T, Mirasa YA, Purwanto D, Amin M, Utsumi T, Soetjipto S, Juniastuti J, Lusida MI. Molecular epidemiology of hepatitis A outbreaks in two districts in Indonesia in 2018: Same subtype, but different strains. Biomed Rep 2020;12:51-8. [PMID: 31929874 DOI: 10.3892/br.2019.1261] [Reference Citation Analysis]
4 Angeleri P, Levite V, Vidiella G, Solari J, Coronel E, Adaszko D, Adaszko A, Moyano C, Bouchet D, Cuello H, Molfese V, Skarzauskas R, Vila M, Falistocco C, Pando MA. Viral hepatitis and Treponema pallidum prevalence in persons who underwent premarital blood tests in Argentina. Sci Rep 2019;9:9611. [PMID: 31270342 DOI: 10.1038/s41598-019-45891-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Tabet E, Gelu-Simeon M, Genet V, Lamontagne L, Piquet-Pellorce C, Samson M. Chlordecone potentiates auto-immune hepatitis and promotes brain entry of MHV3 during viral hepatitis in mouse models. Toxicol Lett 2018;299:129-36. [PMID: 30287270 DOI: 10.1016/j.toxlet.2018.09.014] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Sahin A, Gurocak S, Tunc N, Demirel U, Poyrazoglu OK, Akbulut H, Yalniz M, Toraman ZA, Bahcecioglu IH. Anti-HDV seroprevalance among patients with previous HBV infection. North Clin Istanb 2018;5:132-8. [PMID: 30374479 DOI: 10.14744/nci.2018.01328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Al-Salahi R, Anouar EH, Marzouk M, Abuelizz HA. Anti-HAV evaluation and molecular docking of newly synthesized 3-benzyl(phenethyl)benzo[g]quinazolines. Bioorg Med Chem Lett 2019;29:1614-9. [PMID: 31054861 DOI: 10.1016/j.bmcl.2019.04.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kozak RA, Rutherford C, Richard-greenblatt M, Chau NYE, Cabrera A, Biondi M, Borlang J, Day J, Osiowy C, Ramachandran S, Mayer N, Glaser L, Smieja M. Development and Evaluation of a Molecular Hepatitis A Virus Assay for Serum and Stool Specimens. Viruses 2022;14:159. [DOI: 10.3390/v14010159] [Reference Citation Analysis]
9 Peng J, Liu ZY, Yu XJ, Chen XY, Zhang K, Liu Y, Su YY, Sun CQ. Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase. Arch Virol 2021;166:2299-303. [PMID: 34101005 DOI: 10.1007/s00705-021-05132-9] [Reference Citation Analysis]